Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Latham BioPharm expands
April 2020
SHARING OPTIONS:

CAMBRIDGE, Mass.—Latham BioPharm Group Inc., a provider of life-sciences consulting services, recently added Dr. Thijs Beuming to the team to lead the company’s In Silico Drug Discovery services unit. LBG's new offering complements existing product development capabilities by providing full-service and strategic support for companies seeking to apply in-silico drug discovery methods to streamline drug discovery, design, development and optimization efforts. Beuming comes to LBG with more than 20 years of experience applying computational biophysics, computational chemistry, bioinformatics and cheminformatics to problems in biology and drug discovery, with working knowledge in academia and industry.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.